Skip to main content
. Author manuscript; available in PMC: 2013 Jun 9.
Published in final edited form as: J Rheumatol. 2013 Mar 1;40(5):640–646. doi: 10.3899/jrheum.121043

Figure 5.

Figure 5

Mixed-effects model estimates for percentage of predicted forced vital capacity (FVC%) in subjects with connective tissue disease with usual interstitial pneumonia (CTD-UIP) or non-UIP. Solid line: CTD-UIP, n = 32, surgical lung biopsy = 15. Broken line: CTD-non-UIP, n = 93, surgical lung biopsy = 36. MMF: myco- phenolate mofetil.